Congress funds endometriosis research and equity study for millions of patients
H.R. 6682 — Endometriosis CARE Act · Filed by Nikema Williams (D-GA) · 27 cosponsors · Introduced Dec 11, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the National Institutes of Health and the Department of Health and Human Services to fund research, data collection, and public education about endometriosis—a chronic disease affecting millions of people, predominantly women, that causes severe pain and infertility. It authorizes $54.5 million over five years (2026–2030) to study barriers to treatment, develop better therapies, educate patients and doctors, and examine disparities in diagnosis and care across racial, ethnic, and socioeconomic groups.
Why we flagged it
The bill is a straightforward public-health authorization that funds NIH research, HHS data collection, and patient/provider education on a chronic disease. It contains no regulatory changes, tax provisions, or industry carve-outs—only appropriations and agency directives.
What the text implies
- The bill requires health insurers and state Medicaid programs to report data on endometriosis treatment access, which may increase administrative burden on insurers but will create the first comprehensive national picture of treatment barriers and disparities.
- By mandating a National Academies study on endometriosis disparities across race, ethnicity, geography, sexual orientation, and gender identity, the bill may surface systemic inequities in diagnosis and care that could later drive policy or regulatory changes.
The full analysis lists 3 implications of this text.
Who stands to gain
NIH and HHS (research and administrative funding); National Academies of Sciences, Engineering, and Medicine (study contract); nonprofit organizations and consumer groups (dissemination partnerships)